Figure B (Fig B)
Glatiramer Acetate Injection, Solution
Product Images NDC 82983-429
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Glatiramer Acetate (NDC 82983-429). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ajenat Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure C (Fig C)
This text appears to be a guide on where to avoid applying a certain product or treatment on the body. It mentions specific areas to avoid, such as 2 inches around fleshy areas of the upper hips and belly button, as well as about 2 inches above the knee and 2 inches below the groin on the thighs. It also references the back of the hips, arms, and upper back portion as areas to be cautious around.*
Figure D (Fig D)
Figure E1 (Fig E1)
Figure E2 (Fig E2)
Figure E3 (Fig E3)
Figure F (Fig F)
Figure G (Fig G)
Figure H (Fig H)
Figure I (Fig I)
Figure J (Fig J)
Figure K (Fig K)
Figure L (Fig L.png)
Blister Label (Blister Label 20mg)
This is a description of a prescription-only medication called Glatiramer Acetate Injection, designed for subcutaneous use. Each pre-filled syringe contains 1mL of the solution, with Glatiramer acetate 20 mg and mannitol 40 mg as an inactive ingredient. The medication should be stored in a refrigerator at a temperature ranging from 36°F to 46°F (2°C to 8°C) and protected from light. Distributed by Ajenat Pharmaceuticals, LLC in the USA. Made in China.*
Carton (Carton 20)
This text provides information about a pre-filled syringe containing Glatiramer Acetate Injection, which includes Glatiramer acetate and mannitol as inactive ingredient. It also mentions storage conditions, dosage instructions (20 mg once daily), manufacturing details, and distribution by Ajenat Pharmaceuticals, LLC. Instructions for keeping the syringe refrigerated and protected from light are included. The medication guide is required to be dispensed to each patient.*
Figure 1 (Fig 1)
This information may be related to a clinical trial or study comparing a placebo and Glatiramer Acetate for the prevention of second exacerbation. The text includes statistics such as p-value (0.0005) and Hazard Ratio (0.55), along with data on the occurrence of second exacerbation for each treatment group. Additional details about the study design and results are not available.*
Figure 2 (Fig 2)
Figure A (Fig A)
Syringe Label (Label For 20mg 260119 1)
This is a description for a medication containing Glatiramer Acetate for subcutaneous injection. The NDC code, lot number, expiration date, and distributor information are provided for reference.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
